Clinical Trial Update: Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

View source ↗

Summary

Pfizer-sponsored real-world evidence study on metastatic prostate cancer (metastatic castration-sensitive and metastatic castration-resistant) completed in Finl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Castration-sensitive Prostate Cancer

Snippet

Sponsor: Pfizer | Conditions: Metastatic Castration Sensitive Prostate Cancer (mCSPC), Metastatic Castration Resistant Prostate Cancer (mCRPC) | Status: COMPLETED | Results posted: 2026-01-29